EP0522081A4 - Inhibition of disease associated with immunodeficiency virus infection - Google Patents
Inhibition of disease associated with immunodeficiency virus infectionInfo
- Publication number
- EP0522081A4 EP0522081A4 EP19910908056 EP91908056A EP0522081A4 EP 0522081 A4 EP0522081 A4 EP 0522081A4 EP 19910908056 EP19910908056 EP 19910908056 EP 91908056 A EP91908056 A EP 91908056A EP 0522081 A4 EP0522081 A4 EP 0522081A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- inhibition
- immunodeficiency virus
- virus infection
- disease associated
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50200690A | 1990-03-30 | 1990-03-30 | |
US502006 | 1990-03-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0522081A1 EP0522081A1 (en) | 1993-01-13 |
EP0522081A4 true EP0522081A4 (en) | 1993-06-16 |
Family
ID=23995932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19910908056 Withdrawn EP0522081A4 (en) | 1990-03-30 | 1991-03-29 | Inhibition of disease associated with immunodeficiency virus infection |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0522081A4 (en) |
JP (1) | JPH05506031A (en) |
AU (1) | AU7677891A (en) |
WO (1) | WO1991015224A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6470590A (en) | 1989-10-23 | 1991-04-26 | Smithkline Beecham Corporation | Cyclic anti-aggregatory peptides |
US5643872A (en) * | 1989-10-23 | 1997-07-01 | Smithkline Beecham Corporation | Cyclic anti-aggregatory peptides |
US5445813A (en) * | 1992-11-02 | 1995-08-29 | Bracco International B.V. | Stable microbubble suspensions as enhancement agents for ultrasound echography |
DE4447484C2 (en) * | 1994-04-08 | 1997-07-17 | Deutsches Krebsforsch | Apoptosis inhibitor |
FR2731355B1 (en) * | 1995-03-08 | 1997-05-30 | Neovacs | NOVEL IMMUNOGENS, NOVEL ANTIBODIES, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
BR9607659A (en) * | 1995-03-08 | 1998-12-15 | Neovacs | Immunogen compound composition processes for preparing an immunogenic compound of an anti-protein antibody and an anti-protein antibody fragment and fragment |
US6200575B1 (en) | 1996-03-07 | 2001-03-13 | Neovacs | Non-toxic immunogens derived from a retroviral regulatory protein antibodies preparation process and pharmaceutical compositions comprising them |
US8323928B2 (en) | 1999-08-12 | 2012-12-04 | Pin Pharma, Inc. | Vaccines and immunotherapeutics derived from the human immunodeficiency virus (HIV) transactivator of transcription protein for the treatment and prevention of HIV disease |
US6667151B1 (en) | 1999-08-12 | 2003-12-23 | Inist, Inc. | Vaccines and immunotherapeutics derived from the human immunodeficiency virus (HIV) trans-activator of transcription protein for the treatment and prevention of HIV disease |
WO2006033665A1 (en) | 2004-03-16 | 2006-03-30 | Inist Inc. | Tat-based vaccine compositions and methods of making and using same |
CA2755897C (en) | 2009-03-23 | 2020-01-28 | Nanirx, Inc. | Treatment of cancers with immunostimulatory hiv tat derivative polypeptides |
IT1397569B1 (en) | 2009-12-10 | 2013-01-16 | Icgeb | PEPTIDES AND THEIR DERIVATIVES THAT INHIBIT THE EXTRACELLULAR RELEASE OF HIV-1 PROTEIN TAT AND THE REPLICATION OF HIV-1. |
AU2014329393B2 (en) | 2013-10-04 | 2020-04-30 | Pin Pharma, Inc. | Immunostimulatory HIV Tat derivative polypeptides for use in cancer treatment |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989012461A1 (en) * | 1988-06-16 | 1989-12-28 | St. Louis University | Antagonists of viral transactivating proteins |
WO1992014755A1 (en) * | 1991-02-14 | 1992-09-03 | La Jolla Cancer Research Foundation | A NOVEL INTEGRIN SPECIFICITY FOR THE HIV Tat PROTEIN |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4880779A (en) * | 1987-07-31 | 1989-11-14 | Research Corporation Technologies, Inc. | Method of prevention or treatment of AIDS by inhibition of human immunodeficiency virus |
-
1991
- 1991-03-29 WO PCT/US1991/002157 patent/WO1991015224A1/en not_active Application Discontinuation
- 1991-03-29 EP EP19910908056 patent/EP0522081A4/en not_active Withdrawn
- 1991-03-29 JP JP91507618A patent/JPH05506031A/en active Pending
- 1991-03-29 AU AU76778/91A patent/AU7677891A/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989012461A1 (en) * | 1988-06-16 | 1989-12-28 | St. Louis University | Antagonists of viral transactivating proteins |
WO1992014755A1 (en) * | 1991-02-14 | 1992-09-03 | La Jolla Cancer Research Foundation | A NOVEL INTEGRIN SPECIFICITY FOR THE HIV Tat PROTEIN |
Non-Patent Citations (4)
Title |
---|
JOURNAL OF VIROLOGY vol. 64, no. 2, February 1990, BALTIMORE pages 962 - 965 BRAKE, D.A. ET AL 'Characterization of murine monoclonal antibodies to the tat protein from human immunodeficiency virus type 1' * |
SCIENCE vol. 242, October 1988, LANCASTER, PA US pages 91 - 93 STANLEY E. D'SOUZA ET AL 'Localization of an arg-gly-asp recognition site within an integrin adhesion receptor' * |
See also references of WO9115224A1 * |
THE JOURNAL OF CELL BIOLOGY vol. 111, no. 3, September 1990, NEW YORK pages 1275 - 1281 BRAKE, D.A. ET AL 'Identification of an arg-gly-asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein, tat' * |
Also Published As
Publication number | Publication date |
---|---|
WO1991015224A1 (en) | 1991-10-17 |
AU7677891A (en) | 1991-10-30 |
EP0522081A1 (en) | 1993-01-13 |
JPH05506031A (en) | 1993-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU648616B2 (en) | Disposable garments | |
DE69121211D1 (en) | APPLANATION TONOMETER | |
HU912526D0 (en) | Recombinant marek-type disease virus | |
ZA924150B (en) | Vaccine for human immunodeficiency virus | |
EP0522081A4 (en) | Inhibition of disease associated with immunodeficiency virus infection | |
ZA90245B (en) | Treatment of diseases associated with hiv infections | |
DZ1706A1 (en) | Hepatitis A vaccine. | |
EP0486106A3 (en) | Marek's disease virus vaccine | |
EP0608212A4 (en) | Method of treating viral infection. | |
AP9300513A0 (en) | Compositions for the treatment of infection and disease caused by hepatitis b virus(hbv) | |
EP0471407A3 (en) | New embodiments of the hiv principal neutralizing determinant | |
ZA925305B (en) | Inhibition of non-CD4 midiated HIV infection. | |
EP0563323A4 (en) | Hiv reverse transcriptase vaccine | |
EP0442744A3 (en) | Treatment of viral disease by glycosides | |
GB9020541D0 (en) | Viral growth inhibition | |
ZA914435B (en) | Treatment of disease | |
IL102815A (en) | Pharmaceutical compositions for the treatment of infection caused by the human immunodeficiency virus | |
KR930701105A (en) | Inhibition of herpes virus infection by antisense oligonucleotides | |
DE3865694D1 (en) | PLANTS RESISTANT TO "CUCUMBER MOSAIC VIRUS" INFECTION. | |
EP0655919A4 (en) | Treatment of human viral infections. | |
GB9006924D0 (en) | Prognosis of hepatitis infection | |
GB2240993B (en) | Improvements relating to the handling of hosiery | |
KR910014244U (en) | Tongs' multistage lock | |
LTIP472A (en) | Composition for the treatment of infection and disease caused by hepatit b virus | |
NZ314730A (en) | Use of dideoxycytosine derivatives in the treatment of viral infection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19920923 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19930503 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19940805 |